Vision loss can adversely affect the ability of older adults to perform instrumental activities of daily living (IADL), such as using the telephone, shopping and doing housework, which are all measures of an individual's ...
Aug 21, 2014
0
0
(HealthDay)—Most children treated for moderate amblyopia when younger than 7 years have good visual acuity at 15 years of age, according to a study published in the July issue of JAMA Ophthalmology.
Jul 16, 2014
0
0
An international research project, led by the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, reports that a new oral medication is showing significant progress in restoring vision to patients ...
Jul 14, 2014
0
0
(Medical Xpress)—Bigger brain areas could have evolved to help us perceive more, and more accurately, according to a new study published by scientists at the University of Bath.
Jun 25, 2014
11
0
For adults and children who undergo cataract surgery, implantation of an artificial lens is the standard of care. But a clinical trial suggests that for most infants, surgery followed by the use of contact lenses for several ...
Mar 6, 2014
0
0
Robert Avery, DO, MSCE, of Children's National Health System and colleagues are establishing innovative approaches with technology and medication to improve the vision of young children who have visual pathway glioma, a type ...
Feb 28, 2014
0
0
With a little practice on a computer or iPad—25 minutes a day, 4 days a week, for 2 months—our brains can learn to see better, according to a study of University of California, Riverside baseball players reported in the ...
Feb 17, 2014
0
0
For the third time in one year, the German Institute for Quality and Efficiency in Health Care (IQWiG) dealt with the drug aflibercept. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal ...
Jan 7, 2014
0
0
Nonarteritic anterior ischemic optic neuropathy (NAION) is one of the leading causes of sudden and irreversible loss of vision in older adults. In a prospective randomized trial of 60 patients with NAION, investigators have ...
Nov 19, 2013
0
0
(HealthDay)—Oral pazopanib is well tolerated and improves mean best-corrected visual acuity, central retinal lesion thickness, and central retinal thickness at day 29 in a small, per-protocol, non-rescued population of ...
Oct 11, 2013
0
0
